Fast synthesis could boost drug development
Wednesday, March 19, 2014 - 19:30
in Health & Medicine
Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018.